Your browser doesn't support javascript.
loading
Research progress in autosomal dominant polycystic kidney disease / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences) ; (12): 1179-1187, 2019.
Article in Chinese | WPRIM | ID: wpr-813032
ABSTRACT
Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary disease, mainly caused by polycystic kidney disease 1/2 (PKD1/2) gene mutation. The main manifestation is the formation of multiple progressive enlarged cysts in both kidneys, which can be accompanied by decreased glomerular filtration rate, hypertension, liver cyst and cerebral aneurysm. About 45% of patients will progress to end-stage renal failure before the age of 60. ADPKD gene sequencing can be chosen for suspicious patients with atypical clinical features, no positive family history, and inconspicuous imaging findings. In the ADPKD positive families, imaging examination is the main means of diagnosing ADPKD. Height-adjusted total kidney volume (htTKV) and kidney growth rate are commonly used to monitor ADPKD disease progression and prognosis. There is no effective treatment for ADPKD to stop its progress. Drugs such as tolvaptan and bosutinib can delay the renal disfunction and they have been applied to clinical therapy in Europe and America.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Polycystic Kidney, Autosomal Dominant / Disease Progression / Tolvaptan / Glomerular Filtration Rate / Kidney Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Journal of Central South University(Medical Sciences) Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Polycystic Kidney, Autosomal Dominant / Disease Progression / Tolvaptan / Glomerular Filtration Rate / Kidney Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Journal of Central South University(Medical Sciences) Year: 2019 Type: Article